← World Watch
Disruptionother · July 20, 2026
Samsung Biologics expands into peptides with $1.8b PolyPeptide deal
The acquisition expands peptide manufacturing capacity and shifts supply toward Samsung Biologics' biologics and peptide production.
Source →The trace
How it reaches your house.
Starting from the trigger, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
The causal trace for this event is still being written.